Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pala

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Experimental Diabetes Research|July 13, 2011
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapyIlaria Dicembrini, Laura Pala, Carlo Maria Rotella
Seminars in Oncology|October 3, 2022
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to actionLaura Pala, Tommaso De Pas, Fabio Conforti
Diabetes, Obesity & Metabolism|August 2, 2019
Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusionIlaria Dicembrini, Edoardo Mannucci, Matteo Monami, et al.
Diabetes, Obesity & Metabolism|November 20, 2024
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trialsGiovanni Antonio Silverii, Laura Pala, Barbara Cresci, et al.
Cancers|April 3, 2021
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced MelanomaPier Francesco Ferrucci, Laura Pala, Fabio Conforti, et al.
Cancer Treatment Reviews|April 10, 2020
Thymic epithelial tumors: From biology to treatmentFabio Conforti, Laura Pala, Giuseppe Giaccone, et al.
Eating and Weight Disorders : EWD|July 30, 2014
The therapy of insulin resistance in other diseases besides type 2 diabetesLaura Pala, Valeria Barbaro, Ilaria Dicembrini, et al.
Current Pharmaceutical Design|January 26, 2017
Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular DiseaseAstrid Parenti, Laura Pala, Sara Paccosi, et al.
Anti-Cancer Drugs|February 4, 2020
Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanomaLaura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
World Journal of Psychiatry|March 28, 2015
Assessment of psychological predictors of weight loss: How and what for?Lisa Lazzeretti, Francesco Rotella, Laura Pala, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Experimental Diabetes Research|July 13, 2011
From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapyIlaria Dicembrini, Laura Pala, Carlo Maria Rotella
Seminars in Oncology|October 3, 2022
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to actionLaura Pala, Tommaso De Pas, Fabio Conforti
Diabetes, Obesity & Metabolism|August 2, 2019
Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusionIlaria Dicembrini, Edoardo Mannucci, Matteo Monami, et al.
Diabetes, Obesity & Metabolism|November 20, 2024
Glucagon-like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta-analysis of randomised controlled trialsGiovanni Antonio Silverii, Laura Pala, Barbara Cresci, et al.
Cancers|April 3, 2021
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced MelanomaPier Francesco Ferrucci, Laura Pala, Fabio Conforti, et al.
Cancer Treatment Reviews|April 10, 2020
Thymic epithelial tumors: From biology to treatmentFabio Conforti, Laura Pala, Giuseppe Giaccone, et al.
Eating and Weight Disorders : EWD|July 30, 2014
The therapy of insulin resistance in other diseases besides type 2 diabetesLaura Pala, Valeria Barbaro, Ilaria Dicembrini, et al.
Current Pharmaceutical Design|January 26, 2017
Potential Role for Dendritic Cells in Endothelial Dysfunction, Diabetes and Cardiovascular DiseaseAstrid Parenti, Laura Pala, Sara Paccosi, et al.
Anti-Cancer Drugs|February 4, 2020
Extensive vitiligo associated to response to c-kit inhibitor in metastatic mucosal melanomaLaura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
World Journal of Psychiatry|March 28, 2015
Assessment of psychological predictors of weight loss: How and what for?Lisa Lazzeretti, Francesco Rotella, Laura Pala, et al.
Pageof 13